- ICH GCP
- Amerikanska kliniska prövningsregistret
- Klinisk prövning NCT07708389
970-nm Diode Laser Versus Liquid Nitrogen Cryotherapy in Maxillary Labial Frenectomy (MLF-DL-KRYO)
Comparison of Salivary Cortisol Response and Early Postoperative Outcomes Following 970-nm Diode Laser and Liquid Nitrogen Cryotherapy in Maxillary Labial Frenectomy: A Randomized Single-Blind Clinical Trial
This prospective, randomized, single-blind, assessor-blinded, parallel-group clinical trial aims to compare the effects of 970-nm diode laser and liquid nitrogen cryotherapy in patients requiring maxillary labial frenectomy.
The primary objective is to compare the change in salivary cortisol levels from baseline to postoperative day 2 between the two treatment groups. Secondary objectives include comparison of postoperative pain, edema, interincisal mouth opening, analgesic consumption, operation duration, state anxiety, clinical wound healing, and adverse events.
Eligible adult patients with an indication for maxillary labial frenectomy will be randomly assigned to receive either 970-nm diode laser frenectomy or liquid nitrogen cryotherapy. Salivary cortisol samples and clinical outcomes will be assessed during the early postoperative follow-up period.
Studieöversikt
Status
Intervention / Behandling
Detaljerad beskrivning
Maxillary labial frenulum abnormalities may be associated with diastema, plaque accumulation, periodontal irritation, gingival recession, oral hygiene difficulty, functional discomfort, and esthetic concerns. Frenectomy may be indicated when the frenulum is hypertrophic, short, thick, or inserted close to the interdental papilla.
Conventional scalpel frenectomy is effective but may be associated with intraoperative bleeding, need for suturing, postoperative pain, edema, and reduced patient comfort. Minimally invasive approaches such as diode laser surgery and cryotherapy may offer potential advantages in oral soft tissue procedures.
This study will compare two minimally invasive approaches for maxillary labial frenectomy: 970-nm diode laser and liquid nitrogen cryotherapy. Participants will be randomized into two parallel groups. In the diode laser group, frenectomy will be performed using a 970-nm diode laser at 2 W in continuous wave mode with a 320-micrometer sterile fiber tip using a contact technique. In the liquid nitrogen cryotherapy group, open-spray cryotherapy will be applied to the maxillary labial frenulum region with two freeze-thaw cycles.
The primary endpoint is the change in salivary cortisol level from baseline to postoperative day 2. Secondary endpoints include postoperative day 7 salivary cortisol change, postoperative pain measured by visual analog scale, edema, interincisal mouth opening, total analgesic consumption, operation duration, State-Trait Anxiety Inventory-State score, Landry, Turnbull and Howley wound healing index scores, and postoperative complications or adverse events.
All procedures and salivary sampling will be standardized and performed in the morning to reduce the influence of circadian variation on cortisol measurements. The study will be conducted at the Department of Oral and Maxillofacial Surgery, Faculty of Dentistry, Kutahya Health Sciences University.
Studietyp
Inskrivning (Beräknad)
Fas
- Inte tillämpbar
Kontakter och platser
Studiekontakt
- Namn: Muhammet Yasin Pektaş, Asst. Prof, DDS
- Telefonnummer: +905541351195
- E-post: muhammetyasin.pektas@ksbu.edu.tr
Studieorter
-
-
Kütahya
-
Kütahya, Kütahya, Turkiet (Türkiye), 43020
- Kütahya Health Sciences University Faculty of Dentistry
-
Kontakt:
- Muhammet Yasin Pektaş, Asst. Prof., DDS
- Telefonnummer: +905541351195
- E-post: muhammetyasin.pektas@ksbu.edu.tr
-
Kontakt:
- E-post: mypektas42@gmail.com
-
Huvudutredare:
- Muhammet Yasin Pektaş, Asst. Prof., DDS
-
-
Deltagandekriterier
Urvalskriterier
Åldrar som är berättigade till studier
- Vuxen
- Äldre vuxen
Tar emot friska volontärer
Beskrivning
Inclusion Criteria:
- Age between 18 and 65 years.
- Systemically healthy, ASA I status.
- Clinical indication for maxillary labial frenectomy.
- Ability to attend postoperative follow-up visits.
- Provision of written informed consent.
Exclusion Criteria:
- Systemic or local corticosteroid use within the last 6 months.
- Endocrine disease that may affect cortisol levels.
- Pregnancy or lactation.
- Active oral infection.
- Chronic analgesic or anti-inflammatory drug use.
- Psychiatric medication use.
- Smoking.
- ASA II or higher systemic status.
- Inability to attend follow-up visits.
- Refusal to participate in the study.
Studieplan
Hur är studien utformad?
Designdetaljer
- Primärt syfte: Behandling
- Tilldelning: Randomiserad
- Interventionsmodell: Parallellt uppdrag
- Maskning: Enda
Vapen och interventioner
Deltagargrupp / Arm |
Intervention / Behandling |
|---|---|
|
Experimentell: 970-nm Diode Laser Frenectomy
Participants randomized to this arm will undergo maxillary labial frenectomy using a 970-nm diode laser.
The procedure will be performed with a SiroLaser Advance device at 970 nm wavelength, 2 W power, continuous wave mode, and a 320-micrometer sterile fiber tip using a contact technique.
The total laser application time will be standardized as 2 minutes.
The surgical area will not be sutured and will be left to heal by secondary intention.
|
Maxillary labial frenectomy will be performed using a 970-nm diode laser device at 2 W power in continuous wave mode with a 320-micrometer sterile fiber tip using a contact technique.
The total laser application time will be standardized as 2 minutes.
The surgical area will not be sutured and will be left to heal by secondary intention.
Andra namn:
|
|
Experimentell: Liquid Nitrogen Cryotherapy
Participants randomized to this arm will receive liquid nitrogen cryotherapy applied to the maxillary labial frenulum region using an open-spray technique.
Two freeze-thaw cycles will be performed; each freezing cycle will last 15 seconds, with passive complete thawing between cycles.
No mechanical excision will be performed after cryotherapy.
The target tissue is expected to be eliminated through cryogenic necrosis and secondary healing.
The surgical area will not be sutured.
|
Liquid nitrogen cryotherapy will be applied to the maxillary labial frenulum region using an open-spray technique.
Two freeze-thaw cycles will be performed; each freezing cycle will last 15 seconds, with passive complete thawing between cycles.
No mechanical excision will be performed after cryotherapy, and the surgical area will not be sutured.
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in salivary cortisol level from baseline to postoperative day 2
Tidsram: Baseline and postoperative day 2
|
Salivary cortisol will be measured in unstimulated saliva samples using an ELISA method.
For each participant, the change in salivary cortisol level from the preoperative baseline measurement to postoperative day 2 will be calculated and compared between the two intervention groups.
Results will be recorded in nmol/L.
|
Baseline and postoperative day 2
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Change in salivary cortisol level from baseline to postoperative day 7
Tidsram: Baseline and postoperative day 7
|
Salivary cortisol will be measured in unstimulated saliva samples using an ELISA method.
For each participant, the change in salivary cortisol level from the preoperative baseline measurement to postoperative day 7 will be calculated and compared between the two intervention groups.
Results will be recorded in nmol/L.
|
Baseline and postoperative day 7
|
|
Change in postoperative edema
Tidsram: Baseline, postoperative day 2, and postoperative day 7
|
Postoperative edema will be assessed using standardized facial measurements.
Changes in edema measurements from baseline to postoperative day 2 and postoperative day 7 will be calculated and compared between the two intervention groups.
|
Baseline, postoperative day 2, and postoperative day 7
|
|
Postoperative pain intensity
Tidsram: Postoperative 6 hours, 12 hours, 24 hours, day 2, and day 7
|
Postoperative pain intensity will be assessed using a 0-to-10 visual analog scale, where higher scores indicate greater pain intensity.
|
Postoperative 6 hours, 12 hours, 24 hours, day 2, and day 7
|
|
Change in interincisal mouth opening
Tidsram: Baseline, postoperative day 2, and postoperative day 7
|
Interincisal mouth opening will be measured in millimeters.
Changes from baseline to postoperative day 2 and postoperative day 7 will be calculated and compared between the two intervention groups.
|
Baseline, postoperative day 2, and postoperative day 7
|
|
Total analgesic consumption during the first postoperative week
Tidsram: Postoperative days 0 to 7
|
Analgesic consumption will be recorded as the total number of analgesic tablets used by each participant during the first postoperative week.
|
Postoperative days 0 to 7
|
|
Operation duration
Tidsram: During the intervention procedure
|
Operation duration will be recorded in minutes for each participant and compared between the two intervention groups.
|
During the intervention procedure
|
|
State anxiety score
Tidsram: Baseline, postoperative day 2, and postoperative day 7
|
State anxiety will be assessed using the State-Trait Anxiety Inventory-State form.
Total scores will be recorded preoperatively and on postoperative days 2 and 7, and compared between the two intervention groups.
|
Baseline, postoperative day 2, and postoperative day 7
|
|
Clinical wound healing score
Tidsram: Postoperative days 2, 7, 14, and 21
|
Clinical wound healing will be assessed using the Landry, Turnbull and Howley Wound Healing Index.
Wound healing scores will be recorded on postoperative days 2, 7, 14, and 21 and compared between the two intervention groups.
|
Postoperative days 2, 7, 14, and 21
|
|
Postoperative complications and adverse events
Tidsram: From the intervention procedure through postoperative day 21
|
The occurrence of postoperative complications or adverse events, including unexpected pain, bleeding, infection, wound healing problems, or other procedure-related adverse events, will be recorded during the follow-up period.
|
From the intervention procedure through postoperative day 21
|
Samarbetspartners och utredare
Utredare
- Huvudutredare: Muhammet Yasin Pektaş, Asst. Prof, DDS, Kutahya Health Sciences University, Faculty of Dentistry, Department of Oral and Maxillofacial Surgery
Publikationer och användbara länkar
Allmänna publikationer
- Opaleye T, Okoturo E, Adesina OA, Oyapero A, Salami Y, Wemambu JC. Salivary Cortisol as a Stress Monitor During Third Molar Surgery. J Maxillofac Oral Surg. 2022 Dec;21(4):1112-1118. doi: 10.1007/s12663-020-01480-2. Epub 2020 Nov 22.
- Georgakopoulou E, Loumou P, Sgouros D, Chaurasia A, Panagiotopoulos A. Cryosurgery in oral lesions. J Clin Exp Dent. 2025 Oct 1;17(10):e1257-e1266. doi: 10.4317/jced.63133. eCollection 2025 Oct.
- Sobouti F, Moallem Savasari A, Aryana M, Hakimiha N, Dadgar S. Maxillary labial frenectomy: a randomized, controlled comparative study of two blue (445 nm) and infrared (980 nm) diode lasers versus surgical scalpel. BMC Oral Health. 2024 Jul 25;24(1):843. doi: 10.1186/s12903-024-04364-w.
Studieavstämningsdatum
Studera stora datum
Studiestart (Beräknad)
Primärt slutförande (Beräknad)
Avslutad studie (Beräknad)
Studieregistreringsdatum
Först inskickad
Först inskickad som uppfyllde QC-kriterierna
Första postat (Faktisk)
Uppdateringar av studier
Senaste uppdatering publicerad (Faktisk)
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
Senast verifierad
Mer information
Termer relaterade till denna studie
Nyckelord
Ytterligare relevanta MeSH-villkor
Andra studie-ID-nummer
- MLF-DL-KRYO-2026-01
Plan för individuella deltagardata (IPD)
Planerar du att dela individuella deltagardata (IPD)?
Läkemedels- och apparatinformation, studiedokument
Studerar en amerikansk FDA-reglerad läkemedelsprodukt
Studerar en amerikansk FDA-reglerad produktprodukt
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .